INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4176,2628,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4177,2630,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4178,2631,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4179,2632,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4180,2633,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4181,2638,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4182,2639,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4183,2640,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4184,2642,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4185,2643,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4186,2644,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4187,2647,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4188,2649,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4189,2650,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4190,2651,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4191,2652,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4192,2653,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4193,2654,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4194,2657,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4195,4081,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4196,8164,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4197,10377,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4198,10378,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4199,10379,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4200,11908,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4201,13099,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4202,14349,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4203,14876,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4204,14877,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4205,15492,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4206,16363,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4207,16367,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4208,16373,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4209,16376,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4210,16379,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4211,16383,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4212,16384,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4213,16388,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4214,16389,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4215,16391,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4216,16398,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4217,16399,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4218,16402,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4219,18192,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4220,18194,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4221,20298,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4222,20299,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4223,20300,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4224,20427,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4225,21255,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4226,21429,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4227,22588,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4228,22740,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4229,25055,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4230,25555,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4231,25682,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4232,25684,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4233,26237,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4234,28683,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4235,32068,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.','dairy products','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4236,2590,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4237,2621,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4238,2622,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4239,2624,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4240,2626,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4241,2627,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4242,2628,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4243,2630,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4244,2631,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4245,2632,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4246,2633,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4247,2638,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4248,2639,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4249,2640,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4250,2642,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4251,2643,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4252,2644,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4253,2647,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4254,2649,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4255,2650,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4256,2651,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4257,2652,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4258,2653,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4259,2654,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4260,2657,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4261,4081,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4262,8164,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4263,10377,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4264,10378,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4265,10379,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4266,11908,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4267,13099,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4268,14349,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4269,14876,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4270,14877,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4271,15492,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4272,16363,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4273,16367,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4274,16373,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4275,16376,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4276,16379,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4277,16383,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4278,16384,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4279,16388,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4280,16389,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4281,16391,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4282,16398,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4283,16399,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4284,16402,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4285,18192,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4286,18194,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4287,20298,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4288,20299,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4289,20300,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4290,20427,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4291,21255,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4292,21429,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4293,22588,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4294,22740,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4295,25055,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4296,25555,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4297,25682,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4298,25684,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4299,26237,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4300,28683,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4301,32068,'Ciprofloxacin','Concurrent ingestion of dairy products (milk, yogurt) or calcium-fortified foods (i.e., cereal, orange juice) may decrease the activity of certain oral fluoroquinolone antibiotics.  The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability.  In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved.','orange juice','Moderate','Oral ciprofloxacin should not be taken with dairy products or calcium-fortified foods alone, but may be taken with meals that contain these products.  When taken alone, dairy products or calcium-fortified foods should be ingested at least 2 hours before or after ciprofloxacin administration.  When ciprofloxacin tablets are administered to patients receiving continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for at least 1 hour before and 2 hours after the dose of ciprofloxacin is given.  Patients should be monitored for altered antimicrobial efficacy and switched to intravenous ciprofloxacin if necessary.  If no enteral route besides a jejunostomy tube is available, it is also recommended to switch to intravenous ciprofloxacin.  According to the manufacturer, ciprofloxacin oral suspension should not be administered via nasogastric or feeding tubes due to its physical characteristics.','','','DDInter',0),(4302,13650,'Alectinib','Food significantly enhances the oral bioavailability of alectinib and its major active metabolite, M4.  According to the manufacturer, a high-fat, high-calorie meal increased the combined systemic exposure (AUC) of alectinib and M4 by 3.1-fold following oral administration of a single 600 mg dose of alectinib.','high-fat foods','Moderate','To ensure maximal oral absorption, alectinib should be administered with food.','','','DDInter',0),(4303,2416,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4304,2612,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4305,2614,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4306,2615,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4307,2669,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4308,2671,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4309,3431,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4310,3432,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4311,11143,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4312,13055,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4313,16416,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4314,16419,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4315,16420,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4316,17272,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4317,21672,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4318,25493,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4319,25638,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4320,27870,'Citalopram','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4321,5425,'Cimetidine','Concurrent use of cimetidine and ethanol may result in increased ethanol concentrations.  The mechanism appears to be due to inhibition of gastric alcohol dehydrogenase by cimetidine, leading to increased bioavailability of the alcohol and inhibition of hepatic metabolism of alcohol.','alcohol','Minor','The clinical significance of this interaction is limited.  More importantly, patients requiring cimetidine for gastrointestinal disease should be counseled to avoid alcohol to prevent worsening of their disease.  The other H-2 receptor antagonists appear to have minimal effects on the concentrations of alcohol.','','','DDInter',0),(4322,2696,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4323,2697,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4324,2700,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4325,6787,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4326,6949,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4327,6951,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4328,6953,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4329,6954,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4330,6959,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4331,6960,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4332,6962,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4333,13838,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4334,14977,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4335,15794,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4336,16438,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4337,16442,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4338,16443,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4339,20733,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4340,20799,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4341,20800,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4342,21248,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4343,21443,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4344,21444,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4345,21449,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4346,21612,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4347,21613,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4348,30684,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4349,30685,'Clarithromycin','Grapefruit juice may delay the gastrointestinal absorption of clarithromycin but does not appear to affect the overall extent of absorption or inhibit the metabolism of clarithromycin.  The mechanism of interaction is unknown but may be related to competition for intestinal CYP450 3A4 and/or absorptive sites.','grapefruit juice','Minor','Concomitant use of Clarithromycin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4350,11206,'Clemastine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4351,11208,'Clemastine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4352,20516,'Clemastine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4353,27937,'Clemastine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4354,0,'Clofedanol','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4355,0,'Clobazam','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4356,0,'Clofarabine','The liver is a known target organ for clofarabine toxicity, and concomitant use of other potentially hepatotoxic agents may increase the risk of liver injury.','alcohol','Moderate','Concomitant use of clofarabine with other potentially hepatotoxic agents should be avoided whenever possible (e.g., acetaminophen; alcohol; androgens and anabolic steroids; antituberculous agents; azole antifungal agents; ACE inhibitors; disulfiram; endothelin receptor antagonists; interferons; ketolide and macrolide antibiotics; kinase inhibitors; minocycline; nonsteroidal anti-inflammatory agents; nucleoside reverse transcriptase inhibitors; proteasome inhibitors; retinoids; sulfonamides; tamoxifen; thiazolidinediones; tolvaptan; vincristine; zileuton; anticonvulsants such as carbamazepine, hydantoins, felbamate, and valproic acid; lipid-lowering medications such as fenofibrate, lomitapide, mipomersen, niacin, and statins; herbals and nutritional supplements such as black cohosh, chaparral, comfrey, DHEA, kava, pennyroyal oil, and red yeast rice).  Hepatic function should be monitored during clofarabine administration, and therapy discontinued if grade 3 to 4 liver enzyme or bilirubin elevations occur.  Patients should be advised to seek medical attention if they experience potential signs and symptoms of hepatotoxicity such as fever, rash, itching, anorexia, nausea, vomiting, fatigue, malaise, right upper quadrant pain, dark urine, pale stools, and jaundice.','','','DDInter',0),(4357,0,'Clevidipine','Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.','alcohol','Moderate','Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.','','','DDInter',0),(4358,720,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4359,11056,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4360,11059,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4361,14090,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4362,14091,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4363,14103,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4364,14104,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4365,33730,'Clomipramine','The combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is significantly impaired for several weeks or more following discontinuation of chronic alcohol consumption.','alcohol','Moderate','Patients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic effects, hypotension, arrhythmias) is recommended during alcohol withdrawal.','','','DDInter',0),(4366,720,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4367,11056,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4368,11059,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4369,14090,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4370,14091,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4371,14103,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4372,14104,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4373,33730,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','grapefruit juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4374,720,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4375,11056,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4376,11059,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4377,14090,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4378,14091,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4379,14103,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4380,14104,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4381,33730,'Clomipramine','Limited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially demethylated by CYP450 1A2, 3A3 and 3A4 before undergoing further metabolism to 8-hydroxyclomipramine.  The increase in clomipramine bioavailability may stem from inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.  The precise mechanism by which cranberry juice exerts its effects is unknown, but may involve inhibition of CYP450 isoenzymes.  This interaction has occasionally been exploited in attempts to improve symptomatic control of obsessive compulsive disorder.','cranberry juice','Moderate','Patients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.','','','DDInter',0),(4382,15942,'Clonidine','Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.','alcohol','Moderate','Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.','','','DDInter',0),(4383,15943,'Clonidine','Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.','alcohol','Moderate','Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.','','','DDInter',0),(4384,4293,'Clidinium','Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.','alcohol','Moderate','Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4385,7288,'Clidinium','Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.','alcohol','Moderate','Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4386,16508,'Clidinium','Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.','alcohol','Moderate','Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4387,16567,'Clidinium','Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.','alcohol','Moderate','Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4388,17604,'Clidinium','Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.','alcohol','Moderate','Alcohol should generally be avoided during therapy with anticholinergic agents.  Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4389,623,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4390,624,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4391,833,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4392,836,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4393,2790,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4394,6978,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4395,9926,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4396,21459,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4397,21460,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4398,26216,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4399,26217,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4400,26266,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4401,26267,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4402,26951,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4403,26952,'Clonazepam','Acute ethanol ingestion may potentiate the CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.','','','DDInter',0),(4404,24890,'Clorazepic acid','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4405,2822,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4406,2823,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4407,2824,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4408,2825,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4409,2826,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4410,2828,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4411,7201,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4412,21703,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4413,22439,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4414,25683,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4415,26611,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4416,26612,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4417,29811,'Clozapine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4418,24890,'Alendronic acid','Food significantly decreases the bioavailability of alendronate, possibly to negligible levels.','food','Moderate','Alendronate should be administered with 6 to 8 ounces of plain water, at least 30 minutes before the first food, beverage, or medication of the day.  Patients should remain upright for at least 30 minutes following administration of alendronate.','','','DDInter',0),(4419,1744,'Codeine','Ethanol may potentiate the central nervous system (CNS) depressant effects of opioid analgesics.  Concomitant use may result in additive CNS depression and impairment of judgment, thinking, and psychomotor skills.  In more severe cases, hypotension, respiratory depression, profound sedation, coma, or even death may occur.','alcohol','Moderate','Concomitant use of opioid analgesics with ethanol should be avoided.','','','DDInter',0),(4420,0,'Cobimetinib','Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme, such as cobimetinib.  However, the interaction seems to affect primarily those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability), presumably due to the fact that grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4.','grapefruit juice','Moderate','Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of cobimetinib.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4421,0,'Alfentanil','Ethanol may potentiate the central nervous system (CNS) depressant effects of opioid analgesics.  Concomitant use may result in additive CNS depression and impairment of judgment, thinking, and psychomotor skills.  In more severe cases, hypotension, respiratory depression, profound sedation, coma, or even death may occur.','alcohol','Moderate','Concomitant use of opioid analgesics with ethanol should be avoided.','','','DDInter',0),(4422,2886,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4423,7714,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4424,7718,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4425,16617,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4426,16618,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4427,16651,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4428,30612,'Colchicine','Coadministration with grapefruit juice may increase the serum concentrations of colchicine.  Clinical toxicity including myopathy, neuropathy, multiorgan failure, and pancytopenia may occur.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism and P-glycoprotein efflux in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with colchicine should be advised to avoid the consumption of grapefruit and grapefruit juice, and to contact their physician if they experience symptoms of colchicine toxicity such as abdominal pain, nausea, vomiting, diarrhea, fatigue, myalgia, asthenia, hyporeflexia, paresthesia, and numbness.','','','DDInter',0),(4429,13724,'Alfuzosin','The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.','alcohol','Moderate','Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.','','','DDInter',0),(4430,15074,'Alfuzosin','The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.','alcohol','Moderate','Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.','','','DDInter',0),(4431,25400,'Alfuzosin','The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.','alcohol','Moderate','Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.','','','DDInter',0),(4432,29722,'Alfuzosin','The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.','alcohol','Moderate','Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.','','','DDInter',0),(4433,29723,'Alfuzosin','The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.','alcohol','Moderate','Patients who develop  a flushing reaction after ethanol ingestion (indicates a possible aldehyde dehydrogenase deficiency) should be advised to avoid ethanol or limit their intake.  All patients should be warned about the possibility of orthostatic hypotension with concurrent ethanol use.','','','DDInter',0),(4434,13724,'Alfuzosin','Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.','food','Moderate','To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.','','','DDInter',0),(4435,15074,'Alfuzosin','Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.','food','Moderate','To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.','','','DDInter',0),(4436,25400,'Alfuzosin','Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.','food','Moderate','To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.','','','DDInter',0),(4437,29722,'Alfuzosin','Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.','food','Moderate','To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.','','','DDInter',0),(4438,29723,'Alfuzosin','Administration of alfuzosin with food enhances oral bioavailability.  According to the manufacturer, extent of absorption is 50% higher when administered under fed conditions compared to fasting conditions.','food','Moderate','To ensure maximal oral absorption, alfuzosin should be administered with or immediately after a meal.','','','DDInter',0),(4439,0,'Conjugated estrogens','Coadministration with grapefruit juice may increase the bioavailability of oral estrogens.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruits.','grapefruit juice','Minor','It is not recommended to eat or drink foods containing grapefruit while taking any est','','','DDInter',0),(4440,29699,'Crizotinib','Grapefruit juice may increase the plasma concentrations of crizotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with crizotinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Crizotinib may be taken without regards to food.','','','DDInter',0),(4441,29700,'Crizotinib','Grapefruit juice may increase the plasma concentrations of crizotinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Major','Patients treated with crizotinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Crizotinib may be taken without regards to food.','','','DDInter',0),(4442,0,'Copanlisib','Grapefruit juice may increase the plasma concentrations of copanlisib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism of copanlisib by certain compounds present in grapefruit.','grapefruit juice','Moderate','Patients should avoid the consumption of grapefruit and grapefruit juice during treatment with copanlisib.','','','DDInter',0),(4443,3243,'Cyproheptadine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4444,11631,'Cyproheptadine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4445,11632,'Cyproheptadine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4446,0,'Cycloserine','Coadministration with alcohol may potentiate some of the central nervous system adverse effects of cycloserine and its prodrug, terizidone.  These effects may include dizziness, drowsiness, depression, anxiety, psychoses, memory impairment, confusion, and convulsions.','alcohol','Major','Caution is advised when cycloserine or terizidone is used with caffeine.  Consumption of certain beverages or stimulants with very high caffeine levels should be avoided as a precautionary measure.','','','DDInter',0),(4447,7483,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4448,7489,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4449,7571,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4450,8437,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4451,8438,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4452,16988,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4453,16989,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4454,23013,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4455,23014,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4456,25264,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4457,31131,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4458,33230,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4459,33437,'Cyclobenzaprine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4460,20833,'Aliskiren','Coadministration with orange, apple, or grapefruit juice may significantly decrease the oral bioavailability and renin-inhibiting effect of aliskiren.  The exact mechanism of interaction is unknown, but may include inhibition of OATP2B1-mediated influx of aliskiren in the small intestine, formation of insoluble complexes between fruit juice constituents and aliskiren, and/or increased ionization of aliskiren due to reduced intestinal pH.','grapefruit juice','Moderate','To ensure steady systemic drug levels and therapeutic effects, patients should establish a routine pattern for administration of aliskiren with regard to meals.  Coadministration with orange, apple, or grapefruit juice should be avoided, especially if these juices are to be consumed on a regular basis or shortly before or after aliskiren dosing.','','','DDInter',0),(4461,20833,'Aliskiren','Coadministration with orange, apple, or grapefruit juice may significantly decrease the oral bioavailability and renin-inhibiting effect of aliskiren.  The exact mechanism of interaction is unknown, but may include inhibition of OATP2B1-mediated influx of aliskiren in the small intestine, formation of insoluble complexes between fruit juice constituents and aliskiren, and/or increased ionization of aliskiren due to reduced intestinal pH.','orange juice','Moderate','To ensure steady systemic drug levels and therapeutic effects, patients should establish a routine pattern for administration of aliskiren with regard to meals.  Coadministration with orange, apple, or grapefruit juice should be avoided, especially if these juices are to be consumed on a regular basis or shortly before or after aliskiren dosing.','','','DDInter',0),(4462,0,'Dabrafenib','Food may reduce as well as delay the absorption of dabrafenib.  In study subjects, administration of dabrafenib with a high-fat meal decreased peak plasma concentration (Cmax) and systemic exposure (AUC) by 51% and 31%, respectively, and delayed median Tmax by approximately 3.6 hours compared to administration in the fasted state.','high-fat foods','Moderate','Dabrafenib should be taken at least 1 hour before or 2 hours after a meal.','','','DDInter',0),(4463,963,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4464,3210,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4465,14087,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4466,14422,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4467,25927,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4468,26491,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4469,26492,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4470,26493,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4471,26494,'Cyclosporine','Administration with grapefruit juice (compared to water or orange juice) has been shown to increase blood concentrations of cyclosporine with a relatively high degree of interpatient variability.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Moderate','Patients receiving cyclosporine therapy should be advised to either refrain from or avoid fluctuations in the consumption of grapefruits and grapefruit juice.  Until more data are available, the consumption of red wine or purple grape juice should preferably be avoided or limited.  All oral formulations of cyclosporine should be administered on a consistent schedule with regard to time of day and relation to meals so as to avoid large fluctuations in plasma drug levels.','','','DDInter',0),(4472,4962,'Darunavir','Food enhances the absorption and oral bioavailability of darunavir administered in combination with low-dose ritonavir.  The mechanism is unknown.','food','Moderate','To ensure maximal oral absorption, darunavir coadministered with ritonavir should be taken with food.  The type of food is not important.','','','DDInter',0),(4473,1599,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4474,6775,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4475,7745,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4476,7974,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4477,7975,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4478,8311,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4479,9025,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4480,13384,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4481,13629,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4482,13630,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4483,17105,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4484,17106,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4485,17652,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4486,17653,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4487,19328,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4488,19361,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4489,19362,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4490,22877,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4491,23654,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4492,25693,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4493,29861,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4494,30601,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4495,30602,'Dapagliflozin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia.','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4496,4352,'Darolutamide','Food enhances the oral absorption of darolutamide.  According to the prescribing information, bioavailability of darolutamide increased by 2.0 to 2.5-fold when administered with food.  A similar increase in exposure was observed for the active metabolite keto-darolutamide.','food','Moderate','Darolutamide should be administered with food.','','','DDInter',0),(4497,14119,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4498,17115,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4499,17116,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4500,19401,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4501,19402,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4502,19403,'Darifenacin','The consumption of grapefruit juice may be associated with increased plasma concentrations of darifenacin.  The mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruits.','grapefruit juice','Minor','Concomitant use of Darifenacin with grapefruit or grapefruit juice should generally be avoided.','','','DDInter',0),(4503,3320,'Dantrolene','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4504,17100,'Dantrolene','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4505,17101,'Dantrolene','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4506,25832,'Dantrolene','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4507,5848,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4508,5850,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4509,5852,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4510,10837,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4511,19609,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4512,27431,'Dasatinib','Grapefruit and grapefruit juice may significantly increase the plasma concentrations of dasatinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall induced by certain compounds present in grapefruit.  Because grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4, the magnitude of interaction is greatest for those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability).  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.  Certain preparations of grapefruit juice (e.g., high dose, double strength) have sometimes demonstrated potent inhibition of CYP450 3A4, while other preparations (e.g., low dose, single strength) have typically demonstrated moderate inhibition.','grapefruit juice','Major','Patients treated with dasatinib should avoid consumption of grapefruit, grapefruit juice, and any supplement containing grapefruit extract.  Some authorities recommend close monitoring for toxicity (e.g., myelosuppression, bleeding complications, fluid retention, bradycardia or other conduction disturbances) and a reduction of dasatinib dosage to a range of 20 to 40 mg daily should be considered if there are no alternatives and concomitant use with a potent CYP450 3A4 inhibitor is necessary.','','','DDInter',0),(4513,14130,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4514,17181,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4515,17182,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4516,17183,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4517,21118,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4518,21119,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4519,21120,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4520,25727,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4521,25728,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4522,25729,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4523,26273,'Deferasirox','According to product labeling, the bioavailability of deferasirox was variably increased when taken with a meal.','food','Moderate','To ensure consistent plasma drug levels, deferasirox should be taken on an empty stomach 30 minutes before eating preferably at the same time everyday.','','','DDInter',0),(4524,4889,'Deflazacort','Grapefruit juice may increase the plasma concentrations of 21-desdeflazacort, the active metabolite of deflazacort that is formed by esterases after oral administration and further metabolized by CYP450 3A4 to several inactive metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism in the gut wall by certain compounds present in grapefruit.  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.','grapefruit juice','Moderate','Deflazacort should not be administered with grapefruit juice.','','','DDInter',0),(4525,4890,'Deflazacort','Grapefruit juice may increase the plasma concentrations of 21-desdeflazacort, the active metabolite of deflazacort that is formed by esterases after oral administration and further metabolized by CYP450 3A4 to several inactive metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism in the gut wall by certain compounds present in grapefruit.  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.','grapefruit juice','Moderate','Deflazacort should not be administered with grapefruit juice.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4526,19115,'Deflazacort','Grapefruit juice may increase the plasma concentrations of 21-desdeflazacort, the active metabolite of deflazacort that is formed by esterases after oral administration and further metabolized by CYP450 3A4 to several inactive metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism in the gut wall by certain compounds present in grapefruit.  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.','grapefruit juice','Moderate','Deflazacort should not be administered with grapefruit juice.','','','DDInter',0),(4527,19116,'Deflazacort','Grapefruit juice may increase the plasma concentrations of 21-desdeflazacort, the active metabolite of deflazacort that is formed by esterases after oral administration and further metabolized by CYP450 3A4 to several inactive metabolites.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism in the gut wall by certain compounds present in grapefruit.  In general, the effect of grapefruit juice is concentration-, dose- and preparation-dependent, and can vary widely among brands.','grapefruit juice','Moderate','Deflazacort should not be administered with grapefruit juice.','','','DDInter',0),(4528,0,'Demeclocycline','Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.','dairy products','Moderate','Tetracycline should be administered one hour before or two hours after meals.','','','DDInter',0),(4529,6700,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4530,6704,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4531,8201,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4532,8202,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4533,9215,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4534,14316,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4535,18124,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4536,22787,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4537,22788,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4538,22789,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4539,22790,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4540,24061,'Desmopressin','Food may decrease the rate and extent of absorption of desmopressin following oral administration.','food','Minor','This interaction has a low clinical impact in most patients, especially since oral desmopressin is intended to be administered at bedtime.Nevertheless, the possibility of food effects should be considered before increasing the dose whenever a diminution of effect is noted.  A significant interaction is not expected to occur with the sublingual formulation, since absorption occurs primarily in the oral mucosa, pharynx, and esophagus.','','','DDInter',0),(4541,30888,'Dexmedetomidine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4542,14975,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4543,14976,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4544,25267,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4545,25268,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4546,25272,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4547,25273,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4548,29100,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4549,29101,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4550,31557,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4551,31558,'Desvenlafaxine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4552,20836,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4553,20837,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4554,24011,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4555,24012,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4556,24013,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4557,25127,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4558,25128,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4559,29390,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4560,32907,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4561,32908,'Alogliptin','Alcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar significantly, especially when the alcohol is ingested on an empty stomach or following exercise.  The mechanism involves inhibition of both gluconeogenesis as well as the counter-regulatory response to hypoglycemia','alcohol','Moderate','Patients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled diabetes should limit their alcohol intake to one drink daily for women and two drinks daily for men (1 drink = 5 oz wine, 12 oz beer, or 1.5 oz distilled spirits) in conjunction with their normal meal plan.  Alcohol should not be consumed on an empty stomach or following exercise.','','','DDInter',0),(4562,0,'Deutetrabenazine','Alcohol may potentiate some of the pharmacologic effects of central nervous system (CNS)-active agents.  Use in combination may result in additive CNS depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled against driving, operating machinery, or engaging in potentially hazardous activities requiring mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4563,1168,'Dexbrompheniramine','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4564,0,'Dextroamphetamine','Alcohol may potentiate the cardiovascular effects of amphetamines.','alcohol','Moderate','Concomitant use of amphetamines and alcohol should be avoided if possible, especially in patients with a history of heart disease.','','','DDInter',0),(4565,0,'Desipramine','Concomitant use of ethanol and a tricyclic antidepressant (TCA) may result altered TCA plasma levels and efficacy, and additive impairment of motor skills, especially driving skills.  Acute ethanol ingestion may inhibit TCA metabolism, while chronic ingestion of large amounts of ethanol may induce hepatic TCA metabolism.','alcohol','Moderate','Patients should be advised to avoid alcohol during TCA therapy.  Alcoholics who have undergone detoxification should be monitored for decreased TCA efficacy.  Dosage adjustments may be required.','','','DDInter',0),(4566,14420,'Alpelisib','Food significantly enhances the oral absorption and bioavailability of alpelisib.  When administered with a high-fat high-calorie meal (985 calories with 58.1 g of fat) or a low-fat low-calorie meal (334 calories with 8.7 g of fat) the AUC and Cmax of a single dose of alpelisib was increased by 73% and 84% and 77% and 145%, respectively.  There were no clinically significant differences in alpelisib AUC between the two types of meals.  In addition, food appears to have a more pronounced effect on the solubility of alpelisib than gastric pH.','high-fat foods','Moderate','To ensure maximal oral absorption, alpelisib should be administered with a meal.','','','DDInter',0),(4567,0,'Dextropropoxyphene','Alcohol may have additive CNS- and/or respiratory-depressant effects with propoxyphene.  Misuse of propoxyphene, either alone or in combination with other CNS depressants, has been a major cause of drug-related deaths, particularly in patients with a history of emotional disturbances, suicidal ideation, or alcohol and drug abuse.','alcohol','Major','The use of alcohol during propoxyphene therapy should be avoided.  Patients should be warned not to exceed the recommended dosage of propoxyphene and to avoid activities requiring mental alertness until they know how these agents affect them.','','','DDInter',0),(4568,2871,'Dextromethorphan','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4569,11758,'Dextromethorphan','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4570,11759,'Dextromethorphan','Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.','alcohol','Moderate','Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.  Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.','','','DDInter',0),(4571,0,'Diazoxide','Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.','alcohol','Moderate','Caution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihypertensive drugs.  Patients should be advised to avoid rising abruptly from a sitting or recumbent position and to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia.','','','DDInter',0),(4572,8738,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4573,8739,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4574,8740,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4575,12031,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4576,12033,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4577,12038,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4578,12039,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4579,18468,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4580,18469,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4581,28924,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4582,28925,'Diazepam','Acute alcohol ingestion may potentiate the CNS depression and other CNS effects of many benzodiazepines.  Tolerance may develop with chronic ethanol use.  The mechanism may be decreased clearance of the benzodiazepines because of CYP450 hepatic enzyme inhibition.','alcohol','Moderate','Patients should be advised to avoid alcohol during benzodiazepine therapy.  Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4.  Grapefruit and grapefruit juice should be avoided if an interaction is suspected.  Orange juice is not expected to interact with these drugs.','','','DDInter',0),(4583,98,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4584,192,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4585,193,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4586,195,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4587,196,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4588,198,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4589,351,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4590,370,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4591,796,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4592,827,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4593,983,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4594,986,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4595,2148,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4596,2150,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4597,2151,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4598,2153,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4599,2154,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4600,3349,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4601,3350,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4602,3351,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4603,3354,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4604,3355,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4605,3357,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4606,3358,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4607,3359,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4608,3360,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4609,3362,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4610,3629,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4611,3630,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4612,3631,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4613,3632,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4614,3633,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4615,3634,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4616,3637,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4617,3638,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4618,3769,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4619,3801,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4620,3803,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4621,3804,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4622,3809,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4623,3812,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4624,4262,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4625,4265,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0);
INSERT OR REPLACE INTO food_interactions (id,med_id,trade_name,interaction,ingredient,severity,management_text,mechanism_text,reference_text,source,created_at) VALUES (4626,4266,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4627,4267,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4628,4911,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4629,4923,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4630,4935,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4631,4964,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4632,6397,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4633,6814,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4634,6930,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4635,7945,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4636,9167,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4637,9191,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4638,9193,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4639,9194,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4640,9195,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4641,9198,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4642,9314,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4643,9966,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4644,9968,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4645,9969,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4646,12079,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4647,12111,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4648,12550,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4649,12551,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0),(4650,12554,'Diclofenac','The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss.  The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.','alcohol','Moderate','Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.','','','DDInter',0);
